Kazakhstan and Central Asia: Health System Benchmarking for Georgian Policymakers

Kazakhstan has invested heavily in healthcare reform over the past decade. PHIG examines what the region’s largest health system offers as a benchmark — and what Georgia can learn from its trajectory.

“Kazakhstan’s health system transformation is the most ambitious in the post-Soviet space. Whether it delivers commensurate health outcomes will determine whether the model is exportable.”

WHO Regional Office for Europe. Kazakhstan Health System Review. Copenhagen: WHO/Europe; 2023.[1]

Introduction

Kazakhstan, with a population of approximately 19 million and significant hydrocarbon wealth, has invested more per capita in health system transformation than any other former Soviet republic over the past decade, with health expenditure per capita reaching USD 1,247 (PPP) in 2024 — above Georgia’s USD 1,284 but with a considerably larger public sector share.[2] Its 2020 State Health Programme introduced mandatory social health insurance, electronic health records, and a Primary Health Care (PHC) reform drawing explicitly on Estonian and UK models.

PHIG analyses Kazakhstan’s experience as a benchmark for the South Caucasus and Central Asian region, identifying transferable lessons and important caveats.

Table 1. Kazakhstan Health System Benchmarks vs. Georgia and Regional Peers 2024
Indicator Kazakhstan Georgia Kyrgyzstan Azerbaijan WHO Eur. Avg
Health exp. per capita USD PPP 1,247 1,284 248 692 2,847
Govt. share of health spending (%) 58% 52% 52% 37% 71%
Social health insurance (% CHE) 21% 0% 0% 0% 35%
Life expectancy (years) 73.4 73.8 73.1 74.2 77.5
CVD mortality (per 100,000) 390 412 420 401 172
UHC service coverage index 69 67 62 61 N/A
Physician density (per 1,000) 4.1 5.1 2.2 4.0 3.8

Sources: WHO European Health Information Gateway 2024; WHO Global Health Expenditure Database 2024.[1,2]

Kazakhstan’s PHC Reform: Lessons

Kazakhstan’s PHC reform introduced capitation-based payment for registered patients, electronic referral gating, and a ‘Family Medicine’ model replacing Soviet-era polyclinics. The 2023 WHO evaluation found that GP registration reached 94% of the population, but GP-to-specialist referral rates remained high (42% of GP consultations resulted in specialist referral, compared to 15% in the UK), suggesting that the functional gatekeeping role was not yet consolidated.[1,3]

Figure 1. PHC vs. Specialist Utilisation: Kazakhstan vs. Peers 2024 (consultations per capita)

0 2 4 6 4.8 2.0 Kazakhstan 3.2 3.2 Georgia 5.8 0.9 UK 4.2 1.8 Estonia PHC Specialist

Sources: WHO European Health Information Gateway 2024; NHS England 2024.[1,2,3]

Table 2. Transferable Lessons from Kazakhstan PHC Reform: Applicability to Georgia
Reform Element Kazakhstan Outcome Georgia Context Transferability
Capitation payment for GPs 94% population registered Partial capitation exists High — build on existing
Electronic referral gatekeeping 42% GP→specialist rate (high) No electronic gatekeeping High — Georgia EHR needed
Family medicine model Deployed; consolidating Partially present; fragmented Medium — need faculty dev.
Social health insurance 21% CHE; growing 0% — tax funded only High priority — long lead time
QI linkage to payment Piloted 2023; limited data Not implemented Medium — data capacity first
Rural PHC investment Mobile clinic programme Ongoing but underfunded High — scale needed

Sources: WHO 2023; PHIG 2025.[1,5]

Figure 2. Life Expectancy vs. Health Expenditure: South Caucasus and Central Asia 2024

Health Spending per Capita (USD PPP) vs. Life Expectancy (years) 0 70 73 76 Kyrgyzstan Azerbaijan Kazakhstan Georgia Estonia Health spend per capita USD PPP (x-axis); Life expectancy years (y-axis).

Sources: WHO GHED 2024; WHO European Health Information Gateway 2024.[1,2]

Conclusion

Kazakhstan’s health system experience is instructive for Georgia in three specific areas: the introduction of social health insurance, the electronic health record and referral infrastructure, and the PHC capitation model. All three are transferable to the Georgian context, with appropriate adaptation for scale and administrative capacity. What Kazakhstan’s experience also demonstrates is that health spending and health outcomes do not move in lockstep — Kazakhstan spends comparably to Georgia but achieves slightly lower life expectancy, reflecting the difficulty of converting investment into outcomes without simultaneously addressing alcohol consumption, dietary patterns, and occupational health risk factors prevalent across the region.

References

  1. WHO Regional Office for Europe. Kazakhstan: Health System Review 2023. Health Systems in Transition Series. Copenhagen: WHO/Europe; 2023.
  2. WHO Global Health Expenditure Database 2024. Available from: https://apps.who.int/nha/database
  3. NHS England. GP Referral Data 2023/24. London: NHS England; 2024.
  4. Katsaga A, Kulzhanov M, Karanikolos M, Rechel B. Kazakhstan: Health System Review. Health Syst Transit. 2012;14(4):1–154.
  5. PHIG. Central Asia Health System Benchmarking Report. Tbilisi: PHIG; 2025.

Prof. Giorgi Pkhakadze

Prof. Giorgi Pkhakadze, MD, MPH, PhD
Professor of Public Health, David Tvildiani Medical University | Chair, Public Health Institute of Georgia | Founder, Accréditation Sans Frontières
Published on behalf of the PHIG Analysis and Intelligence Team · Tbilisi, Georgia
PHIG

Public Health Institute of Georgia

Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network